Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin ( rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U / mL and 100 U / mL concentrate diluted to 1 U / mL in healthy males-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin ( rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U / mL and 100 U / mL concentrate diluted to 1 U / mL in healthy males

Published:2021-09-08 Issue:12 Volume:23 Page:2679-2686
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Hompesch Marcus¹,Hawryluk Aleksandra²^ORCID,Hernandez Moises¹,Uchil Beena³,Wilmington Alyssa⁴,Peterson Lucas⁴^ORCID

Affiliation:

1. ProSciento, Inc. Chula Vista California

2. Baxter Healthcare Corporation, Worldwide Medical Warsaw Poland

3. Celerity Pharmaceuticals, LLC Rosemont Illinois

4. Baxter Healthcare Corporation, Worldwide Medical Deerfield Illinois

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14520

Reference31 articles.

1. Standards of medical care in diabetes;The American Diabetes Association;J Clin Appl Res Educ,2020

2. Management of Diabetes and Hyperglycemia in Hospitals

3. Perioperative management of diabetes;Marks JB;Am Fam Physician.,2003

4. Survey of hospital systems and common serious medication errors

5. Insulin delivery methods: Past, present and future

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2023-02-01

2. How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers;Frontiers in Pharmacology;2022-07-22